Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice
Hong Shen, … , M. Bishr Omary, Liangyou Rui
Hong Shen, … , M. Bishr Omary, Liangyou Rui
Published March 19, 2019
Citation Information: J Clin Invest. 2019;129(6):2305-2317. https://doi.org/10.1172/JCI124376.
View: Text | PDF
Research Article Hepatology

Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice

  • Text
  • PDF
Abstract

Chronic alcohol consumption causes liver injury, inflammation, and fibrosis, thereby increasing morbidity and mortality. Paradoxically, modest drinking is believed to confer metabolic improvement, but the underlying mechanism remains elusive. Here, we have identified a hepatoprotective brain/brown adipose tissue (BAT)/liver axis. Alcohol consumption or direct alcohol administration into the brain stimulated hypothalamic neural circuits and sympathetic nerves innervating BAT and dramatically increased BAT uncoupling protein 1 (Ucp1) expression and activity in a BAT-sympathetic nerve-dependent manner. BAT and beige fat oxidized fatty acids to fuel Ucp1-mediated thermogenesis, thereby inhibiting lipid trafficking into the liver. BAT also secreted several adipokines, including adiponectin, which suppressed hepatocyte injury and death. Genetic deletion of Ucp1 profoundly augmented alcohol-induced liver steatosis, injury, inflammation, and fibrosis in male and female mice. Conversely, activation of BAT and beige fat through cold exposure suppressed alcoholic liver disease development. Our results unravel an unrecognized brain alcohol-sensing/sympathetic nerve/BAT/liver axis that counteracts liver steatosis and injury.

Authors

Hong Shen, Lin Jiang, Jiandie D. Lin, M. Bishr Omary, Liangyou Rui

×

Figure 6

Brain alcohol-sensing activates BAT.

Options: View larger image (or click on image) Download as PowerPoint
Brain alcohol-sensing activates BAT.
(A–B) Differentiated (A) and primar...
(A–B) Differentiated (A) and primary (B) brown adipocytes were treated with ethanol for 5–18 hours. Ucp1 mRNA levels were measured by qPCR and normalized to 18S levels (n = 3 per group). (C–G) C57BL/6 male mice were housed at 30°C and centrally administrated with alcohol for 3 weeks. (C) BAT TAG levels (normalized to BAT weight; n = 5 per group). (D) Representative BAT sections. TH areas were normalized to the total areas (n = 3 mice per group). (E) BAT extracts were immunoblotted with the indicated antibodies. (F) BAT gene expression (normalized to 18S levels; n = 4–5 per group). (G) BAT OCR (normalized to BAT weight, n = 5 mice per group). (H, I) C57BL/6 males were centrally injected with alcohol, and brains were harvested 2 hours later. Brain sections were stained with anti–c-Fos antibody, and c-Fos+ cells were quantified in different hypothalamic areas. PBS, n = 3; EtOH, n = 3. Scale bars: 200 μm. Data are presented as mean ± SEM. *P < 0.05, 2-tailed unpaired Student’s t test.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts